Back to Neurology
NeurologyvModified (Warlow 1980s)Evidence-Based

Modified Rankin Scale for Neurologic Disability

Measures the degree of disability or dependence in daily activities of people who have suffered a stroke or other causes of neurological disability

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
mrs score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Modified Rankin Scale for Neurologic Disability is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Single ordinal scale from 0-6: 0 = No symptoms, 1 = No significant disability, 2 = Slight disability, 3 = Moderate disability, 4 = Moderately severe disability, 5 = Severe disability, 6 = Dead.

Clinical Pearls & Practice Notes

  • Most widely used outcome scale in acute stroke trials and clinical practice
  • Originally developed by John Rankin in 1957, modified by Charles Warlow in 1980s
  • Provides common language for describing degree of disability after neurological events
  • Assessment should use standardized interview to reduce subjectivity
  • Consider patient's ability to work, maintain hobbies, social connections, and independence in ADLs
  • Scores 0-2 generally considered functional independence
  • Scores 3-5 represent increasing levels of dependence
  • Score 6 indicates death
  • Inter-rater reliability improved with structured interview protocols
  • Important predictor of quality of life and healthcare resource utilization
  • Used to determine eligibility for stroke interventions and rehabilitation services
  • Key endpoint in stroke clinical trials and quality improvement initiatives

Evidence & Literature Citations

  1. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957 Jul;2(7):200-15. doi: 10.1177/003693305700200704.
  2. Warlow C, Dennis M, van Gijn J, et al. Stroke: A Practical Guide to Management. Oxford: Blackwell Scientific Publications; 2001.
  3. Bruno A, Shah N, Lin C, Close B, Hess DC, Davis K, Baute V, Switzer JA, Waller JL, Nichols FT. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke. 2010 May;41(5):1048-50. doi: 10.1161/STROKEAHA.109.571562.
  4. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007 Mar;38(3):1091-6. doi: 10.1161/01.STR.0000258355.23810.c6.

Score Interpretation Ranges

No Symptoms0 – 0 pts

No symptoms at all

No Significant Disability1 – 1 pts

Able to carry out all usual duties and activities

Slight Disability2 – 2 pts

Unable to carry out all previous activities but can look after own affairs

Moderate Disability3 – 3 pts

Requires some help but able to walk unassisted

Moderately Severe Disability4 – 4 pts

Unable to attend to bodily needs without assistance and unable to walk unassisted

Severe Disability5 – 5 pts

Bedridden, incontinent and requiring constant nursing care

Dead6 – 6 pts

Death

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.